Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xulei Tang

Showing results (21-30 of 163) with videos related to

Pageof 17
Sort By:
Clinical Endocrinology|August 19, 2014
The status of 25-hydroxyvitamin D across the spectrum of glucose tolerance among middle-aged and elderly Chinese individualsConghui Guan, Donghu Zhen, Xulei Tang, et al.
Bioscience Reports|September 6, 2021
MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3Songbo Fu, Chengxu Ma, Xulei Tang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2020
Matrine induces papillary thyroid cancer cell apoptosis in vitro and suppresses tumor growth in vivo by downregulating miR-182-5pSongbo Fu, Nan Zhao, Gaojing Jing, et al.
Biomolecules|June 26, 2025
Targeting CD4+ T Cell Glucose Metabolism: A Novel Immunotherapeutic Approach for Type 1 DiabetesYing Niu, Na Wang, Leiying Qiao, et al.
Molecular and Cellular Endocrinology|August 4, 2024
Chiglitazar attenuates high-fat diet-induced nonalcoholic fatty liver disease by modulating multiple pathways in miceLijuan Liu, Weiming Sun, Xulei Tang, et al.
Frontiers in Endocrinology|October 14, 2021
NLRP3 Inflammasome: A New Target for Prevention and Control of Osteoporosis?Na Jiang, Jinyang An, Kuan Yang, et al.
BMC Endocrine Disorders|March 9, 2018
A predictive model of thyroid malignancy using clinical, biochemical and sonographic parameters for patients in a multi-center settingJia Liu, Dongmei Zheng, Qiang Li, et al.
Frontiers in Endocrinology|December 3, 2021
miRNA, lncRNA and circRNA: Targeted Molecules Full of Therapeutic Prospects in the Development of Diabetic RetinopathyXingyu Chang, Guomao Zhu, Zongyan Cai, et al.
Journal of Clinical Pharmacology|December 21, 2020
Endocrine Adverse Events Caused by Different Types and Different Doses of Immune Checkpoint Inhibitors in the Treatment of Solid Tumors: A Meta-Analysis and Systematic ReviewYaxian Yang, Jingfang Liu, Kaili Yang, et al.
Bone|December 25, 2022
Exposure to famine in every stage of life and the risk of osteoporosis and fractures later in life: A cross-sectional studyMengdi Yang, Hongtao Yin, Donghu Zhen, et al.
Pageof 17

Showing results (21-30 of 163) with videos related to

Sort By:
Pageof 17
Clinical Endocrinology|August 19, 2014
The status of 25-hydroxyvitamin D across the spectrum of glucose tolerance among middle-aged and elderly Chinese individualsConghui Guan, Donghu Zhen, Xulei Tang, et al.
Bioscience Reports|September 6, 2021
MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3Songbo Fu, Chengxu Ma, Xulei Tang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2020
Matrine induces papillary thyroid cancer cell apoptosis in vitro and suppresses tumor growth in vivo by downregulating miR-182-5pSongbo Fu, Nan Zhao, Gaojing Jing, et al.
Biomolecules|June 26, 2025
Targeting CD4+ T Cell Glucose Metabolism: A Novel Immunotherapeutic Approach for Type 1 DiabetesYing Niu, Na Wang, Leiying Qiao, et al.
Molecular and Cellular Endocrinology|August 4, 2024
Chiglitazar attenuates high-fat diet-induced nonalcoholic fatty liver disease by modulating multiple pathways in miceLijuan Liu, Weiming Sun, Xulei Tang, et al.
Frontiers in Endocrinology|October 14, 2021
NLRP3 Inflammasome: A New Target for Prevention and Control of Osteoporosis?Na Jiang, Jinyang An, Kuan Yang, et al.
BMC Endocrine Disorders|March 9, 2018
A predictive model of thyroid malignancy using clinical, biochemical and sonographic parameters for patients in a multi-center settingJia Liu, Dongmei Zheng, Qiang Li, et al.
Frontiers in Endocrinology|December 3, 2021
miRNA, lncRNA and circRNA: Targeted Molecules Full of Therapeutic Prospects in the Development of Diabetic RetinopathyXingyu Chang, Guomao Zhu, Zongyan Cai, et al.
Journal of Clinical Pharmacology|December 21, 2020
Endocrine Adverse Events Caused by Different Types and Different Doses of Immune Checkpoint Inhibitors in the Treatment of Solid Tumors: A Meta-Analysis and Systematic ReviewYaxian Yang, Jingfang Liu, Kaili Yang, et al.
Bone|December 25, 2022
Exposure to famine in every stage of life and the risk of osteoporosis and fractures later in life: A cross-sectional studyMengdi Yang, Hongtao Yin, Donghu Zhen, et al.
Pageof 17